Aerial view of Cape Town's central skyline at sunset with modern skyscrapers and golden sky

the CBD

the cbd

In 2025, the world of CBD is experiencing a decisive turning point. Between hot news, molecular innovations, regulatory threats and market explosion, the cbd has never been so present in discussions. Whether you are a curious consumer, a professional in the sector or simply looking for well-being, this article gives you a clear, complete and updated overview of CBD at the end of 2025. Buckle up, let's dive together into the fascinating world of this unique molecule.

Essential CBD publications in 2025

Legal CBD products in 2025: a clear and reassuring guide

The legal framework for CBD in France has evolved significantly. Today, products must contain less than 0.3% THC and come from hemp varieties authorized at the European level. This is recalled in the complete guide to legal CBD products in 2025. This document also details the new molecules that are making headlines: CPR, THC-X and even the mysterious Muscimol, extracted from the fly agaric. Yes, you read that right.

The French market, for its part, is expected to exceed 900 million euros by the end of 2025. This growth is driven in particular by sleep oils, sublingual lozenges and hemp cosmetics, which are well-established in consumer habits.

The strongest CBD of 2025: what's new?

If you thought you'd seen it all, think again. This year, products based on powerful molecules like THC-X and CPR are redefining the notion of intense relaxation. A recently published guide to the strongest CBDs reviews the effects, uses and recommended dosages of these new substances. Be warned, sensations are guaranteed.

Papy CBD and Kiweed: premium varieties in the spotlight

In an article published in Le Losange magazine, Papy CBD unveils its new high-end indoor varieties. Carefully cultivated, these flowers impress with their aromatic richness and controlled potency. For their part, Kiweed's greenhouse varieties offer a more accessible alternative without sacrificing quality. A winning duo for enlightened connoisseurs.

Regulatory challenges of CBD in 2025

Article 23 of the 2026 Finance Bill: a narrowly avoided threat

The famous Article 23 of the 2026 Finance Bill almost disrupted the entire ecosystem. It provided for a monopoly for tobacconists, a ban on online sales and taxation similar to that of tobacco. Fortunately, the National Assembly voted for its repeal, a victory welcomed by the sector. But beware, the Senate could still revisit the issue before December 23.

This situation was analyzed in detail in our article on CBD trends in 2025, which highlights the economic stakes and risks for jobs in the sector.

Increase in intoxications: the other side of CBD

Since 2021, cases of intoxication linked to cannabis-derived products have multiplied. In December 2025, a TF1 investigation highlighted serious cases, including that of a young man who almost jumped from his balcony after consuming a poorly identified product. As a result, cannabis derivatives have been banned since June 3, 2025. See the full investigation.

Taxation of vaping: CBD saved

Another relief for the sector: senators refused to apply an excise duty on non-nicotinized CBD products. This decision, taken as part of the 2026 budget, helps preserve the accessibility of e-liquids and other forms of CBD vape. An essential point for regular consumers.

The concrete benefits of CBD today

An ally for everyday life

CBD can now be easily integrated into wellness routines. Oils for sleep, skin balms, hemp creams or THC-free e-liquids: the options are numerous. New molecules like CPR or THC-X offer more targeted effects, with clearly defined legality. To learn more about what users are really looking for, consult our analysis of consumer expectations.

Extended medical access

Good news for patients: the medical cannabis experiment has been extended until March 31, 2026. This concerns serious pathologies such as neuropathic pain or chemotherapy side effects. Healthcare professionals are trained in the use of these treatments, and customary precautions are well regulated.

Concrete examples of recent uses

Legal and varied products

In 2025, consumers can choose from a wide range of legal products: flowers, oils, resins, all containing less than 0.3% THC. Among the novelties, CPR is praised for its powerful relaxation, while Muscimol, from fly agaric, is as intriguing as it is appealing.

Premium varieties for connoisseurs

Papy CBD and Kiweed offer high-end options for those looking for a more refined experience. Grown indoors or in greenhouses, these flowers are laboratory tested and comply with current regulations. Their richness in terpenes and high CBD content make them highly appreciated products.

CBD vape, still popular

Thanks to the absence of taxation, CBD vape remains an accessible and popular option. Nicotine-free, it allows you to enjoy the relaxing effects of CBD without addiction. A choice appreciated by former smokers and novices in natural wellness alike.

The French CBD market: key figures 2025

The CBD market in France is booming. It will likely reach 900 million euros by the end of the year. This growth is fueled by products embedded in the daily lives of French people: oils, lozenges, cosmetics, e-liquids. Demand remains strong, despite regulatory uncertainties.

To better understand the dynamics of this market, also discover our article on CBD trim, an increasingly popular product in specialized shops.

Frequently asked questions about CBD in December 2025

Is CBD legal in 2025?

Yes. Since December 29, 2022, CBD flowers and leaves containing less than 0.3% THC are authorized for sale and consumption, provided they come from controlled European varieties.

What products are authorized?

All products complying with the order of December 30, 2021 are authorized. This includes flowers, oils, resins and cosmetics, provided the THC content is less than 0.3%.

Is CBD a narcotic?

No. Unlike THC-rich cannabis, CBD is not classified as a narcotic. It can therefore be sold freely, in compliance with current regulations.

News of the week: what to remember

  • Repeal of Article 23 of the 2026 Finance Bill: the National Assembly voted to repeal this controversial article. A victory welcomed by industry players, as highlighted by Planposey.
  • Refusal of vaping tax: the Senate excluded non-nicotinized CBD products from the scope of the excise duty planned for 2026.
  • Increase in intoxications: a TF1 investigation highlighted several serious cases, leading to the ban on cannabis derivatives since June 2025.
Image produit

December 2025 marks a decisive turning point for the CBD market in France. Between nomadic innovations, a return to classics and the rise of new cannabinoids, consumers are looking for natural, effective solutions adapted to their daily lives. If you are wondering what the current CBD trends are and how they are transforming uses, this article provides you with a complete, concrete and up-to-date analysis.

Explosion of nomadic formats and personalized microdoses

December 2025 saw a real craze for nomadic CBD formats. Transdermal patches, roll-ons, sticks to apply directly to the skin or microdoses of 2 to 5 mg to take on the go: practicality has become the norm. These formats particularly appeal to busy urban dwellers, athletes and active people looking for quick and discreet relief.

But that's not all. These products are now enriched with synergies with adaptogens such as ashwagandha, reishi or rhodiola. The result: an amplified effect on stress, sleep, concentration or muscle recovery. An example? The CBD + ashwagandha patch, applied in the morning for a tension-free day, saw a 38% increase in sales in just three weeks.

The CBD.fr website confirms this dynamic in its analysis of the French market, highlighting the booming nomadic and personalized products.

Why are these formats so popular?

  • Discretion: perfect for use in the office, on public transport or when traveling.
  • Precise dosage: ideal for beginners or targeted microdoses.
  • Fast effect: especially with roll-ons and skin absorption patches.

The strong comeback of CBD resin

While it was thought to be reserved for purists, CBD resin is making a spectacular comeback. Concentrated, aromatic, and often more authentic than oils or flowers, it appeals to connoisseurs and novices alike. In December 2025, searches for CBD resin jumped by 45% according to data from specialized blogs.

This phenomenon is explained by several factors:

  • A complete sensory experience: taste, texture, smell… resin offers a raw contact with hemp.
  • Increased effectiveness: often more concentrated in active ingredients.
  • A return to basics: consumers are looking for authenticity and simplicity.

On the Chanvrery website, there is also an increased interest in more "roots", organic and artisanal CBD products, in a logic of responsible consumption.

The new cannabinoids that are making headlines

Since September 2025, the CBD market has seen the emergence of new cannabinoids that are disrupting habits. They are no longer just a laboratory curiosity, but sought-after alternatives in specialized and online stores.

Focus on the most popular

  • CBG: nicknamed "the cannabinoid of power", it is appreciated for its energizing and stimulating effect.
  • CBC: integrated into premium full spectrum formulas, it acts in synergy with other molecules for an enhanced entourage effect.
  • CBN and CBN+: praised for improving sleep quality, without habituation effects.
  • HPC and CPR: reserved for experienced users, these high-intensity cannabinoids generate as much interest as caution.

This rise in power is accompanied by new concerns about traceability, legality (≤0.3% THC) and personalization of formulas. Experts recommend getting well-informed before trying these molecules, notably through reliable guides like this one.

The most frequently asked questions about CBD in December 2025

Internet users seek to understand what is happening in the CBD market. Here are the most frequent questions:

  1. What are the CBD market trends in France in 2025?
  2. What products will dominate: full spectrum oils, gummies, resins, cosmetics?
  3. What formats and dosages for beginners?

These questions reflect a desire to consume better, in complete legality, with a growing interest in daily well-being. To delve deeper into these topics, you can consult this detailed article on frequently asked questions in CBD shops.

CBD as a response to everyday ailments

Urban stress, sleep disorders, post-sport recovery, mental focus for gaming… CBD is now integrated into a wide variety of wellness routines. It is used in infusions, cosmetics, or even in microdoses before a video game session to enter a "flow state".

Purchasing behaviors are evolving accordingly: consumers test, compare, look for traceable, organic products adapted to their lifestyle. This trend is confirmed in this article which lists good CBD deals in 2025.

Persistent doubts and market responses

Despite the enthusiasm, some concerns remain. Consumers are questioning:

  • The actual effectiveness of products versus their marketing
  • The quality and traceability of ingredients
  • Legal compliance, especially regarding THC levels
  • The risk of overdose for beginners
  • The potential psychoactive effects of new powerful cannabinoids

In response, brands are focusing on transparency: certificates of analysis, complete traceability, educational guides and enhanced customer support. The market is professionalizing, and this is excellent news for users.

An increasingly segmented audience

In 2025, two consumer profiles are clearly distinguished:

  • Beginners: attracted by microdoses, practical formats and educational guides.
  • Experts: seeking powerful products such as boosted resins, adaptogenic synergies or cannabinoids like CBN+ or CPR.

This segmentation is also reflected in online searches, where keywords such as "CBD resin 2025" or "CBD gaming" are exploding. For an overview of upcoming trends, this article offers an in-depth analysis of purchasing behaviors.


Leave a comment

Please note, comments must be approved before they are published